results
Jump to
11 Results Found
  • Unichem Labs Q3 PAT seen up 12.9% to Rs 23.2 cr: KR Choksey Jan 13, 2017 01:16 PM IST

    Unichem Labs Q3 PAT seen up 12.9% to Rs 23.2 cr: KR Choksey

    Net Sales are expected to decrease by 4.4 percent Q-o-Q (up 12.7 percent Y-o-Y) to Rs 345 crore, according to KR Choksey.

  • Secondary sales growing above industry average: Unichem Jan 20, 2014 01:10 PM IST

    Secondary sales growing above industry average: Unichem

    Unichem Labs logged a 12.4 percent growth in secondary sales-- made by distributors to chemists-during the December quarter when the industry grew at 5 percent, said Rakesh Parikh, VP Finance.

  • US showing good growth; EMs steady: Unichem Labs Oct 21, 2013 01:38 PM IST

    US showing good growth; EMs steady: Unichem Labs

    The drug firm reported a 3.22 percent increase in net profit to Rs. 36.2 crore for the quarter ended September 30 as sales rose.

  • Hope to sustain export margins in FY13: Unichem Lab Oct 22, 2012 01:00 PM IST

    Hope to sustain export margins in FY13: Unichem Lab

    Rakesh Parikh, VP Finance & CFO of Unichem Laboratories said exports are driving its revenue growth. Going forward, he hopes to maintain the export margins for the rest of the financial year.

  • See strong performance by pharma in Mar quarter: KR Choksey Apr 05, 2012 02:45 PM IST

    See strong performance by pharma in Mar quarter: KR Choksey

    According to the report on earnings preview for the quarter ended March 2012, KR Choksey expects the pharma sector will show strong performance in the domestic pharmaceuticals market mainly due to recovery in Indian pharma market.

  • Pharma stocks results preview for Q3FY12: KRChoksey Jan 11, 2012 06:20 PM IST

    Pharma stocks results preview for Q3FY12: KRChoksey

    KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong quarter in terms of top-line growth mainly due to improved performance in the Indian pharmaceutical market, launch of limited competitive products in the US market & rupee depreciation.

  • Pharmaceutical results preview for Q3FY12: Emkay Jan 10, 2012 06:34 PM IST

    Pharmaceutical results preview for Q3FY12: Emkay

    Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the sector is expected to report a growth of 18% YoY (5% QoQ) in revenues partly driven by Rupee depreciation which is likely to be 4-5% of the overall growth.

  • Unichem Sept qtr PAT seen down 42% at Rs 19 cr: KR Choksey Oct 15, 2011 04:05 PM IST

    Unichem Sept qtr PAT seen down 42% at Rs 19 cr: KR Choksey

    KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Unichem Labs September quarter net sales are expected to go up by 11% at Rs 194 crore, year-on-year, (YoY) basis.

  • Unichem Labs Jun qtr PAT seen at Rs 18cr: KRChoksey Jul 11, 2011 04:05 PM IST

    Unichem Labs Jun qtr PAT seen at Rs 18cr: KRChoksey

    KRChoksey has come out with its earning estimates on pharma sector for the quarter ended June 2011. According to the research firm, Unichem Labs June quarter sales are expected to go up by 5% at Rs 196 crore, year-on-year, (YoY) basis.

  • Unichem Labs Dec qtr PAT seen down 27% at Rs 24.7cr: Karvy Jan 12, 2011 04:13 PM IST

    Unichem Labs Dec qtr PAT seen down 27% at Rs 24.7cr: Karvy

    Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Unichem Labs December quarter sales are expected to go up by 13.7% at Rs 196.5 crore, Year-on-Year, (YoY) basis.

  • Unichem Labs Dec qtr PAT seen down at Rs 26.9cr: Emkay Jan 10, 2011 06:47 PM IST

    Unichem Labs Dec qtr PAT seen down at Rs 26.9cr: Emkay

    Emkay Global Financial Services has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Unichem Labs December quarter sales are expected to go up by 11.7% to Rs 192.9 crore, Year-on-Year, (Y-o-Y) basis.

Sections